Annual Report

Overview

The report describes Kyowa Kirin's FY2019 transformation into a globally managed specialty pharmaceutical company, supported by One Kyowa Kirin and expanding overseas products. It formalizes CSV materiality through a quarterly Group CSR Committee process and reports environmental priorities including a 20% global CO2 reduction target by 2030 from 2015. Consolidated revenue was ¥305,820 million for 2019, while the report also covers natural, human, and social capital disclosures.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2019
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services